Reedland Capital Partners


Our Team Our senior management team is comprised of professionals and experienced executives with extensive records of performance in a diverse range of industries. We are extremely client-oriented and each of our client companies is always represented and serviced directly by one of the highly experienced managing principals of our firm. Principals & Managing Directors Robert K. Schacter, President Thomas J. Griesel, Senior Vice-President David M. Schachter, Managing Director Sanford Zweifach, Managing Director Matthew Geller, Ph.D., Managing Director Professional Staff Jason E. Cohen, Vice-President
Robert K. Schacter, President Mr. Schacter is a founder of the firm and brings with him over 20 years of investment banking and securities industry experience. Prior to forming Reedland in 1998, Mr. Schacter began his investment career in 1983 at Paine Webber, Inc., where he became one of the youngest satellite office managers in the firm's history, assisted with private placement transactions for a number of the country's pioneer biotechnology companies and traded those securities for his clients in the secondary market. In 1986, Mr. Schacter joined Smith Barney, Harris Upham & Co. as Vice President of Retail Sales. Four years later, he joined Wharton Capital as Senior Vice President, where he was responsible for securing secondary debt and raising equity capital for oil and gas industry companies. In 1991, Mr. Schacter became Vice President of Sales at Lehman Brothers, where he was responsible for servicing and managing institutional bond accounts. Prior to forming Reedland in 1998, Rob was a Managing Director at Shoreline Pacific Institutional Finance, where he was responsible for originating and helping structure & negotiate more than $750 million in private equity financings for publicly-listed emerging growth companies. ^ Return to Top


	Thomas J. Griesel, Senior Vice President Mr. Griesel is a co-founder of the firm and brings with him more than 30 years of experience in the securities industry and corporate financial operations. In his role as Senior Vice President of Reedland, Tom is responsible for overseeing the firm’s daily operations and providing private placement advisory services to Reedland’s corporate and institutional clients. Prior to founding Reedland Capital Partners with Mr. Schacter in 1998, Tom was Managing Director of private placements at Shoreline Pacific Institutional Finance, where together with Mr. Schacter, he was responsible for originating and structuring private equity offerings for publicly traded companies. Previously, Tom spent 20 years in various corporate operations positions at a large public utility company, providing him with a comprehensive understanding of the operations and financing needs of small to mid-sized companies. Tom is a registered securities principal. ^ Return to Top


	David M. Schachter, Managing Director Mr. Schachter heads Reedland's institutional finance division for private, rapid growth-oriented companies. In that capacity, he structures and arranges institutional equity financing for early, mid- and late-stage private companies, focusing primarily on revenue-based companies whose products or services have had strong adoption in the marketplace. Mr. Schachter also provides extensive advice with respect to business/strategic plans, investor presentations/roadshows and methods to maximize a company's pre-money valuation. Mr. Schachter also structures and arranges institutional debt financing for both publicly traded and private companies. He focuses on recapitalizations that enable companies to grow internally or through acquisitions by structuring loans that create greater cash availability and fewer earnings and other operationally constraining loan covenants. He also focuses on assisting companies in structuring less expensive institutional alternatives to high-yield debt syndications. Mr. Schachter has also worked extensively with a network of lenders that specialize in refinancing companies in turnaround situations or are otherwise in breach of loan covenants where a new lender relationship would benefit the company. Prior to joining Reedland upon its inception in early 1998, Mr. Schachter was a securities and financial institutions transactional attorney for over 12 years (initially with Pillsbury, Madison & Sutro and then as a Partner at a boutique firm based in Los Angeles that specialized in representing financial institutions and broker-dealers). In that capacity, he developed extensive experience and expertise in structuring and negotiating both private and public secondary debt and equity transactions and in negotiating registration statement and related offering material filings with the SEC and other regulatory agencies. Mr. Schachter received an M.B.A. degree in corporate finance from the University of San Diego School of Business where he graduated magna cum laude. ^ Return to Top

Sanford Zweifach, Managing Director Mr. Zweifach joined Reedland in 2005 and heads our life sciences M&A/advisory efforts, bringing with him 15 years of proven experience in investment banking, investing, business development, mergers & acquisitions, and management. Prior to joining Reedland, Sandy was CEO of Pathways Diagnostics, Inc., a biomarker development company. Previously, from 1997 to 2003, Sandy was CFO of Bay City Capital, a merchant bank specializing in the biotech/life science industry, where he was responsible for oversight of the firm's finance department as well as President of the firm's M&A and financing division. From 1995 to 1997 Sandy was President and CFO of Epoch Biosciences, which was acquired by Nanogen in 2004. Previously, Sandy was a Certified Public Accountant for Coopers & Lybrand and held various investment banking positions focusing on biotech. Mr. Zweifach received his BA in Biology from UC San Diego and holds an MS in Human Physiology from UC Davis. ^ Return to Top

Matthew Geller, Ph.D., Managing Director Dr. Geller joined Reedland in 2008, bringing with him over 14 years of experience as a senior biotech analyst and and healthcare investment banker. At Reedland, Dr. Geller's focus is on arranging private equity financing for life science companies. From 2006-2008, Dr. Geller was head of healthcare banking at Rodman and Renshaw. Throughout this period, the group was consistently ranked #1 on the Street for PIPES and registered direct stock offerings. Dr. Geller was also responsible for M&A and advisory assignments for both public and private biotech companies. From 1994-2005, Dr. Geller was Managing Director and Senior Biotechnology Analyst at Oppenheimer and CIBC World Markets. Dr. Geller was named one of the best stock-pickers in biotechnology in the Wall Street Journal's "Best on the Street Analysts Survey", was selected by Institutional Investor magazine as a member of its All-Star Home-Run Hitters research team, and has been a member of the publication's All-America Research team. Dr. Geller is often quoted in industry and general press, including the Wall Street Journal, the New York Times, and has made frequent television appearances on CNBC, Bloomberg television and CNN. Dr. Geller has also served as a consultant to venture capital firms, biotech companies and portfolio managers and analysts. Earlier in his career, Dr. Geller was a professor at U.C. Berkeley, the University of Michigan, Ann Arbor and Duke University, and published extensively. A graduate of Yale University, from which he earned a bachelors degree with advanced standing in mathematics; Dr. Geller received a master's degree in mathematics from the University of California, San Diego and a Ph.D. in computer science from the University of California, Berkeley. Dr. Geller is fluent in French and German. ^ Return to Top


Jason E. Cohen, Vice President Mr. Cohen joined Reedland Capital Partners in July of 1998 and is responsible for conducting research and legal due diligence relative to Reedland’s corporate and institutional clients and providing logistical support to Reedland’s members. Previously, from 1995 until 1998, Jason was employed by Shoreline Pacific Institutional Finance of Sausalito, California as that firm’s Contracts Administrator. In this position, Jason facilitated the closing arrangements of over 50 private equity offerings, playing an instrumental role in the consummation of over $500 million of institutional investment in nationally-listed public companies, and working closely with the firm’s bankers, in-house legal counsel, client issuers, and investors. From 1991 through 1995, Jason was employed as a paralegal for a New York law firm specializing in bankruptcy/creditor rights, litigation and commercial law. Jason earned his undergraduate degree in Political Science from Colgate University in 1991. ^ Return to Top